MAYZENT vs TASCENSO ODT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MAYZENT and TASCENSO ODT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MAYZENT	TASCENSO ODT
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	SIPONIMOD	FINGOLIMOD LAURYL SULFATE
Manufacturer	Novartis	Cycle
Dosage forms	Tablet	Tablet, orally disintegrating
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 6 to 9 days (average apparent terminal half-life)
Treats	Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis	Relapsing-Remitting Multiple Sclerosis

mayzent tascenso odt

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

SIPONIMOD

FINGOLIMOD LAURYL SULFATE

Manufacturer

Novartis

Cycle

Dosage forms

Tablet

Tablet, orally disintegrating

Drug class

—

Boxed warning

None

Half-life

—

about 6 to 9 days (average apparent terminal half-life)

Treats

Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Mayzent and Tascenso ODT?

Mayzent contains Siponimod, while Tascenso ODT contains Fingolimod Lauryl Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.